CHEK2 and colorectal carcinoma: With reference to CHEK2, following the large study by Mundt et al. [13], which reported no increased risk of CRC in individuals with germline CHEK2 pathogenic variants, the NCCN guidelines [28] have withdrawn the recommendation for colonoscopy screening in these patients, unless there is a significant family history of CRC.